Ethics of Remdesivir in COVID Treatment
Remember that in 2018 Remdesivir,
one of my favorite targets,
Remdesivir was too unethical to put into Ebola clinical trials
in Africa because it had a 53%
kill rate published in medical journals.
Ebola doesn't have a 53% kill rate
but it was chosen in April and May of 2020
to be the drug of choice to treat COVID.
This drug was too unethical to use in an African clinical trial
because it was killing 53% of the people that it was given to
and we had Anthony Fauci,
Deborah Burke sitting next to the president going
we need to use Remdesivir despite the fact that the
World Health Organization said it was unethical to use it.
Here's the problem.
The problem is as long as the financial interest that
dictates what product is going to be promoted is the one making the declaration of the pandemic,
we have no possibility for accountability.
We have no possibility for justice and what we do is
we allow people who were formed out of the eugenics office,
Carnegie Mellon in 1913,
that same group of people that were the same group of people that established the World Health Organization in 1953,
that same group of people are the ones who are making this decision
and I don't know how you feel about eugenics
but I have a problem with it.
End of transcript · 228 words